Citi on Zimmer Biomet (ZBH): 'This is another step in its transformation path'
Tweet Send to a Friend
Citi analyst Joanna Wuensch reiterated a Neutral rating and $104.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst comments "Zimmer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
